EDITOR: | March 9th, 2015

GrowPros recent equity interest and vision as a diversified cannabis venture firm

| March 09, 2015 | No Comments

Brown-Ryan-GrowProsMarch 9, 2015 — In a special InvestorIntel interview, Publisher Tracy Weslosky speaks with Ryan Brown, CEO of GrowPros Cannabis Ventures Inc. (CSE: GCI) about the recent agreement with MMPR applicant Herbaceous Inc. who has been issued a ready to build letter as well as GrowPros’ ongoing mandates focused on equipment and the service aspect of the industry. As a leading expert in the sector, Ryan also provides an update on the development of the Canadian MMPR licensing system and renewed market interest.

Tracy Weslosky: Ryan I really like that we’re having the opportunity to speak with you because you’re a really well-respected hydroponic expert in the overall cannabis and medicinal marijuana sector. As a leading expert in this sector, can you tell us a little bit about your mandate?

Ryan Brown: Yes, Growpros’ mandate is to be a diversified venture firm. We’re looking at investing into many different facets of this rapidly changing and emerging industry.

Tracy Weslosky: Of course you just put out some really big news. You just announced that you invested in a company that came to you, right, that’s been issued a ready to build letter?

Ryan Brown: Yeah. One of the areas that we’re focusing on is applicant producers that are in the late stages of the application process. This company contacted us — they were looking for capital for some restructuring of their internal operations. We made a deal with them, which in exchange for 10% equity in their company we would get their business ready for capital investment then in turn we would introduce them to some private capital that is willing to invest in this project.

Tracy Weslosky: Of course, for everyone out there we’re trying to bring investors who might not normally have invested in the medicinal marijuana sector into the Canadian market because we have a very sophisticated infrastructure as we’re attempting to build with the MMPR licensing system. Can you explain a little bit more about this please?

Ryan Brown: Well, what you have right now is 14 licensed companies as well as another 7 that are licensed to produce. The industry is growing. The amount of patients registered with the system is increasing tenfold every month. We see this as being a long-term opportunity for production, distribution as well as all of the industries that cater to these production facilities for the next year to two years.

Tracy Weslosky: Of course, you have some top investors on your board of directors. With an interesting model, GrowPros is seeking acquisitions with revenue?

Ryan Brown: Yeah, we’re really focused on late stage applicants as well as companies that are generating revenue within the medical cannabis industry or those generating revenue looking at reaching out into the medical cannabis industry.

Tracy Weslosky: Of course, we see a market turnaround happening right now. Companies that are leaders, like yourself, that are — have revenue are obviously going to be on the forefront of a lot of investors’ stock watch. Can you tell us any of the deals that you currently have in place?

Ryan Brown: Yeah, well, we’re looking at, obviously looking at the equipment sector, the lights, the LD equipment that goes into these large production facilities as well as the patient acquisition and a few interesting technology opportunities that have presented themselves in and around the patient end of the industry and certain technologies that can help the licensed producers as well as these care clinics manage their patient flow and run more efficient businesses….for more information, click here

Disclaimer: GrowPros Cannabis Ventures Inc. (CSE: GCI) is an advertorial member of InvestorIntel.


Tracy Weslosky is the founder and CEO for InvestorIntel Corp. (2001-Present), a leading online source of investor information that since 2001 has provided public market ... <Read more about Tracy Weslosky>

Copyright © 2022 InvestorIntel Corp. All rights reserved. More & Disclaimer »

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.